Oculis Holding AG (OCS)

USD 18.87

(6.43%)

Revenue Summary of Oculis Holding AG

  • Oculis Holding AG's latest annual revenue in 2023 was 883 Thousand CHF , down -3.18% from previous year.
  • Oculis Holding AG's latest quarterly revenue in 2024 Q2 was 245 Thousand CHF , up 10.36% from previous quarter.
  • Oculis Holding AG reported a annual revenue of 912 Thousand CHF in annual revenue 2022, down -5.0% from previous year.
  • Oculis Holding AG reported a annual revenue of 960 Thousand CHF in annual revenue 2021, down -3.32% from previous year.
  • Oculis Holding AG reported a quarterly revenue of 222 Thousand CHF for 2024 Q1, up 20.0% from previous quarter.
  • Oculis Holding AG reported a quarterly revenue of 185 Thousand CHF for 2023 Q4, down -15.53% from previous quarter.

Annual Revenue Chart of Oculis Holding AG (2023 - 2020)

Historical Annual Revenue of Oculis Holding AG (2023 - 2020)

Year Revenue Revenue Growth
2023 883 Thousand CHF -3.18%
2022 912 Thousand CHF -5.0%
2021 960 Thousand CHF -3.32%
2020 993 Thousand CHF 0.0%

Peer Revenue Comparison of Oculis Holding AG

Name Revenue Revenue Difference
NeuroSense Therapeutics Ltd. - USD -Infinity%
Psyence Biomedical Ltd. - USD -Infinity%
XOMA Corporation 4.75 Million USD 81.442%
Mesoblast Limited 5.9 Million USD 85.039%
Xeris Biopharma Holdings, Inc. 163.91 Million USD 99.461%
Aptorum Group Limited 431.37 Thousand USD -104.693%
Qualigen Therapeutics, Inc. 5.2 Million USD 83.035%
HilleVax, Inc. - USD -Infinity%
Rocket Pharmaceuticals, Inc. - USD -Infinity%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Precision BioSciences, Inc. 48.72 Million USD 98.188%
Dyadic International, Inc. 2.89 Million USD 69.539%
Intensity Therapeutics, Inc. - USD -Infinity%
IDEAYA Biosciences, Inc. 23.38 Million USD 96.224%
Eton Pharmaceuticals, Inc. 31.64 Million USD 97.209%
VYNE Therapeutics Inc. 424 Thousand USD -108.255%
EyePoint Pharmaceuticals, Inc. 46.01 Million USD 98.081%
Adaptive Biotechnologies Corporation 170.27 Million USD 99.481%
Tenaya Therapeutics, Inc. - USD -Infinity%
IGM Biosciences, Inc. 2.13 Million USD 58.545%
Opthea Limited 261.85 Thousand USD -237.204%
Milestone Pharmaceuticals Inc. 1 Million USD 11.7%
Abeona Therapeutics Inc. 3.5 Million USD 74.771%
Tonix Pharmaceuticals Holding Corp. 7.76 Million USD 88.633%
Ligand Pharmaceuticals Incorporated 131.31 Million USD 99.328%
NextCure, Inc. - USD -Infinity%
Inhibikase Therapeutics, Inc. 260.5 Thousand USD -238.964%
Ovid Therapeutics Inc. 391.69 Thousand USD -125.431%
CASI Pharmaceuticals, Inc. 33.87 Million USD 97.394%
Arcturus Therapeutics Holdings Inc. 157.74 Million USD 99.44%
Syros Pharmaceuticals, Inc. 9.93 Million USD 91.113%
Senti Biosciences, Inc. 2.56 Million USD 65.521%
Apollomics, Inc. 821 Thousand USD -7.552%
PureTech Health plc 3.33 Million USD 73.483%
Oncternal Therapeutics, Inc. 785 Thousand USD -12.484%
Barinthus Biotherapeutics plc 802 Thousand USD -10.1%
Kymera Therapeutics, Inc. 78.59 Million USD 98.876%
ChromaDex Corporation 83.57 Million USD 98.943%
Monopar Therapeutics Inc. - USD -Infinity%
Akebia Therapeutics, Inc. 194.62 Million USD 99.546%
Sangamo Therapeutics, Inc. 176.23 Million USD 99.499%
Dermata Therapeutics, Inc. - USD -Infinity%
Gritstone bio, Inc. 1.33 Million USD 33.659%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
Fate Therapeutics, Inc. 63.53 Million USD 98.61%
BioXcel Therapeutics, Inc. 1.38 Million USD 36.014%
Fortress Biotech, Inc. 84.51 Million USD 98.955%
Checkpoint Therapeutics, Inc. 103 Thousand USD -757.282%
Atossa Therapeutics, Inc. - USD -Infinity%
Lyell Immunopharma, Inc. 130 Thousand USD -579.231%
Celcuity Inc. - USD -Infinity%
ContextLogic Inc. 287 Million USD 99.692%
GH Research PLC - USD -Infinity%
HOOKIPA Pharma Inc. 20.12 Million USD 95.613%
Cassava Sciences, Inc. - USD -Infinity%
Cyclacel Pharmaceuticals, Inc. 420 Thousand USD -110.238%
ImmuCell Corporation 17.47 Million USD 94.946%
Amarin Corporation plc 306.91 Million USD 99.712%
TG Therapeutics, Inc. 233.66 Million USD 99.622%
X4 Pharmaceuticals, Inc. - USD -Infinity%
Acelyrin, Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Seer, Inc. 15.18 Million USD 94.184%
Novavax, Inc. 983.7 Million USD 99.91%
Phathom Pharmaceuticals, Inc. 682 Thousand USD -29.472%
Jazz Pharmaceuticals plc 3.83 Billion USD 99.977%
AnaptysBio, Inc. 17.15 Million USD 94.853%
Aptevo Therapeutics Inc. - USD -Infinity%
PMV Pharmaceuticals, Inc. - USD -Infinity%
AbCellera Biologics Inc. 38.02 Million USD 97.678%
CorMedix Inc. - USD -Infinity%
Cartesian Therapeutics, Inc. 26 Million USD 96.604%
Marker Therapeutics, Inc. 3.31 Million USD 73.332%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 99.993%
Aptose Biosciences Inc. - USD -Infinity%
ZyVersa Therapeutics, Inc. - USD -Infinity%
Soligenix, Inc. 839.35 Thousand USD -5.199%
Century Therapeutics, Inc. 2.23 Million USD 60.492%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.633%
TransCode Therapeutics, Inc. - USD -Infinity%
Kura Oncology, Inc. - USD -Infinity%
RAPT Therapeutics, Inc. - USD -Infinity%
Ardelyx, Inc. 124.45 Million USD 99.291%
Ainos, Inc. 122.11 Thousand USD -623.107%
TScan Therapeutics, Inc. 21.04 Million USD 95.805%
Ocean Biomedical, Inc. - USD -Infinity%
Prothena Corporation plc 91.37 Million USD 99.034%
CytomX Therapeutics, Inc. 101.21 Million USD 99.128%
Autolus Therapeutics plc 1.69 Million USD 47.998%
Mineralys Therapeutics, Inc. - USD -Infinity%
Adaptimmune Therapeutics plc 60.28 Million USD 98.535%
Eterna Therapeutics Inc. 68 Thousand USD -1198.529%
Celularity Inc. 22.77 Million USD 96.122%
Rallybio Corporation - USD -Infinity%
GRI Bio, Inc. 21.76 Million USD 95.943%
Xenetic Biosciences, Inc. 2.53 Million USD 65.236%
Omeros Corporation - USD -Infinity%
INmune Bio, Inc. 155 Thousand USD -469.677%
Heron Therapeutics, Inc. 127.04 Million USD 99.305%
SAB Biotherapeutics, Inc. 2.23 Million USD 60.563%
Pasithea Therapeutics Corp. - USD -Infinity%
Entero Therapeutics, Inc. - USD -Infinity%
Humacyte, Inc. - USD -Infinity%
Atara Biotherapeutics, Inc. 8.57 Million USD 89.7%
Coherus BioSciences, Inc. 257.24 Million USD 99.657%
Immunocore Holdings plc 249.42 Million USD 99.646%
Cocrystal Pharma, Inc. - USD -Infinity%
Verastem, Inc. - USD -Infinity%
Pliant Therapeutics, Inc. 1.58 Million USD 44.114%
Histogen Inc. 3.76 Million USD 76.572%
Surrozen, Inc. - USD -Infinity%
Blueprint Medicines Corporation 249.38 Million USD 99.646%
Organovo Holdings, Inc. 109 Thousand USD -710.092%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
IO Biotech, Inc. - USD -Infinity%
MEI Pharma, Inc. 65.29 Million USD 98.648%
GT Biopharma, Inc. - USD -Infinity%
Centessa Pharmaceuticals plc 6.85 Million USD 87.115%
Hepion Pharmaceuticals, Inc. - USD -Infinity%
Cabaletta Bio, Inc. - USD -Infinity%
Summit Therapeutics Inc. - USD -Infinity%
Alaunos Therapeutics, Inc. 5000.00 USD -17560.0%
Marinus Pharmaceuticals, Inc. 30.98 Million USD 97.151%
BioRestorative Therapies, Inc. 145.8 Thousand USD -505.624%
Turnstone Biologics Corp. 19.3 Million USD 95.426%
Pulmatrix, Inc. 7.29 Million USD 87.901%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd - USD -Infinity%
Aurinia Pharmaceuticals Inc. 175.51 Million USD 99.497%
Vigil Neuroscience, Inc. - USD -Infinity%
Intellia Therapeutics, Inc. 36.27 Million USD 97.566%
Cytokinetics, Incorporated 7.53 Million USD 88.274%
Exelixis, Inc. 1.83 Billion USD 99.952%
Nurix Therapeutics, Inc. 76.98 Million USD 98.853%
Apellis Pharmaceuticals, Inc. 396.59 Million USD 99.777%
Evogene Ltd. 5.64 Million USD 84.344%
Replimune Group, Inc. - USD -Infinity%
PDS Biotechnology Corporation - USD -Infinity%
Hoth Therapeutics, Inc. - USD -Infinity%
Jasper Therapeutics, Inc. - USD -Infinity%
ESSA Pharma Inc. - USD -Infinity%
TNF Pharmaceuticals, Inc. - USD -Infinity%
BioLineRx Ltd. 4.8 Million USD 81.604%
Avid Bioservices, Inc. 139.91 Million USD 99.369%
Insmed Incorporated 305.2 Million USD 99.711%
VistaGen Therapeutics, Inc. 1.06 Million USD 17.011%
Zentalis Pharmaceuticals, Inc. - USD -Infinity%
Sagimet Biosciences Inc. 2 Million USD 55.85%
MediWound Ltd. 18.68 Million USD 95.275%
MiMedx Group, Inc. 321.47 Million USD 99.725%
OmniAb, Inc. 34.16 Million USD 97.415%
Alector, Inc. 97.06 Million USD 99.09%
Seres Therapeutics, Inc. 126.32 Million USD 99.301%
PTC Therapeutics, Inc. 937.82 Million USD 99.906%
Mereo BioPharma Group plc 10 Million USD 91.17%
Zai Lab Limited 266.71 Million USD 99.669%
Revance Therapeutics, Inc. 234.04 Million USD 99.623%
Syndax Pharmaceuticals, Inc. - USD -Infinity%
Aura Biosciences, Inc. - USD -Infinity%
Immunic, Inc. - USD -Infinity%
Dyne Therapeutics, Inc. - USD -Infinity%
Tarsus Pharmaceuticals, Inc. 17.44 Million USD 94.939%
Veracyte, Inc. 361.05 Million USD 99.755%
InMed Pharmaceuticals Inc. 4.59 Million USD 80.795%
FibroGen, Inc. 147.75 Million USD 99.402%
SeaStar Medical Holding Corporation - USD -Infinity%
Allakos Inc. - USD -Infinity%
scPharmaceuticals Inc. 13.59 Million USD 93.504%
Fulcrum Therapeutics, Inc. 2.8 Million USD 68.52%
Corcept Therapeutics Incorporated 482.37 Million USD 99.817%
Adial Pharmaceuticals, Inc. - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 147.8 Thousand USD -497.409%
Amylyx Pharmaceuticals, Inc. 380.78 Million USD 99.768%
Precigen, Inc. 6.22 Million USD 85.815%
Fortrea Holdings Inc. 3.1 Billion USD 99.972%
KalVista Pharmaceuticals, Inc. - USD -Infinity%
Incyte Corporation 3.69 Billion USD 99.976%
Alzamend Neuro, Inc. - USD -Infinity%
Cara Therapeutics, Inc. 20.96 Million USD 95.789%
XBiotech Inc. - USD -Infinity%
Aligos Therapeutics, Inc. 15.52 Million USD 94.314%
Jasper Therapeutics, Inc. - USD -Infinity%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
CRISPR Therapeutics AG 371.2 Million USD 99.762%
Akero Therapeutics, Inc. - USD -Infinity%
Eliem Therapeutics, Inc. - USD -Infinity%
Lyra Therapeutics, Inc. 1.55 Million USD 43.325%
Foghorn Therapeutics Inc. 34.15 Million USD 97.415%
Agenus Inc. 156.31 Million USD 99.435%
Kiora Pharmaceuticals, Inc. - USD -Infinity%
Y-mAbs Therapeutics, Inc. 84.81 Million USD 98.959%
Theravance Biopharma, Inc. 57.42 Million USD 98.462%
Ultragenyx Pharmaceutical Inc. 434.24 Million USD 99.797%
Metagenomi, Inc. Common Stock 44.75 Million USD 98.027%
Lexaria Bioscience Corp. 226.2 Thousand USD -290.349%
BioCryst Pharmaceuticals, Inc. 331.41 Million USD 99.734%
UroGen Pharma Ltd. 82.71 Million USD 98.932%
Gain Therapeutics, Inc. 55.18 Thousand USD -1500.217%
Sutro Biopharma, Inc. 153.73 Million USD 99.426%
Creative Medical Technology Holdings, Inc. 9000.00 USD -9711.111%
Lisata Therapeutics, Inc. - USD -Infinity%
Chemomab Therapeutics Ltd. - USD -Infinity%
Stoke Therapeutics, Inc. 8.78 Million USD 89.943%
Chimerix, Inc. 324 Thousand USD -172.531%
Reneo Pharmaceuticals, Inc. - USD -Infinity%
Outlook Therapeutics, Inc. - USD -Infinity%
60 Degrees Pharmaceuticals, Inc. 253.57 Thousand USD -248.223%
Pluri Inc. 326 Thousand USD -170.859%
Cue Biopharma, Inc. 5.49 Million USD 83.916%
MeiraGTx Holdings plc 14.01 Million USD 93.701%
Aprea Therapeutics, Inc. 583.23 Thousand USD -51.398%
Cadrenal Therapeutics, Inc. Common Stock - USD -Infinity%
Cidara Therapeutics, Inc. 63.9 Million USD 98.618%
ProMIS Neurosciences, Inc. - USD -Infinity%
CalciMedica, Inc. - USD -Infinity%
Scholar Rock Holding Corporation - USD -Infinity%
Sana Biotechnology, Inc. - USD -Infinity%
Elicio Therapeutics, Inc. - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
Adlai Nortye Ltd. American Depositary Shares 4.99 Million USD 82.325%
Nutriband Inc. 2.08 Million USD 57.656%
Protara Therapeutics, Inc. - USD -Infinity%
Vor Biopharma Inc. - USD -Infinity%
Roivant Sciences Ltd. 124.79 Million USD 99.292%
ProKidney Corp. - USD -Infinity%
Applied Therapeutics, Inc. 9.99 Million USD 91.164%
Daré Bioscience, Inc. 2.8 Million USD 68.553%
BridgeBio Pharma, Inc. 9.3 Million USD 90.508%
Titan Pharmaceuticals, Inc. 184 Thousand USD -379.891%
Bicycle Therapeutics plc 26.97 Million USD 96.727%
Tango Therapeutics, Inc. 36.52 Million USD 97.583%
Galectin Therapeutics Inc. - USD -Infinity%
Revolution Medicines, Inc. Warrant 11.58 Million USD 92.375%
Atai Life Sciences N.V. 314 Thousand USD -181.21%
Renovaro Biosciences Inc. - USD -Infinity%
Aerovate Therapeutics, Inc. - USD -Infinity%
MediciNova, Inc. 1 Million USD 11.7%
Praxis Precision Medicines, Inc. 2.44 Million USD 63.915%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -5074.333%
GeoVax Labs, Inc. - USD -Infinity%
Protagonist Therapeutics, Inc. 60 Million USD 98.528%
Axsome Therapeutics, Inc. 270.6 Million USD 99.674%
Biomea Fusion, Inc. - USD -Infinity%
RenovoRx, Inc. - USD -Infinity%
Erasca, Inc. - USD -Infinity%
Cullinan Oncology, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
4D Molecular Therapeutics, Inc. 20.72 Million USD 95.739%
Kiniksa Pharmaceuticals, Ltd. 270.25 Million USD 99.673%
bluebird bio, Inc. 29.49 Million USD 97.006%
Ventyx Biosciences, Inc. - USD -Infinity%
Pieris Pharmaceuticals, Inc. 42.81 Million USD 97.937%
Imunon, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 99.964%
BioAtla, Inc. - USD -Infinity%
Allogene Therapeutics, Inc. 95 Thousand USD -829.474%
Larimar Therapeutics, Inc. - USD -Infinity%
DBV Technologies S.A. 15.72 Million USD 94.386%
Fortress Biotech, Inc. 84.51 Million USD 98.955%
Avidity Biosciences, Inc. 9.56 Million USD 90.764%
Kezar Life Sciences, Inc. 7 Million USD 87.386%
aTyr Pharma, Inc. 353 Thousand USD -150.142%
Viridian Therapeutics, Inc. 314 Thousand USD -181.21%
EyeGate Pharmaceuticals, Inc. 12.05 Thousand USD -7222.332%
Galecto, Inc. - USD -Infinity%
Akari Therapeutics, Plc - USD -Infinity%
Tevogen Bio Holdings Inc. - USD -Infinity%
Halozyme Therapeutics, Inc. 829.25 Million USD 99.894%
Lexicon Pharmaceuticals, Inc. 1.2 Million USD 26.661%
Entera Bio Ltd. - USD -Infinity%
Travere Therapeutics, Inc. 145.23 Million USD 99.392%
Sensei Biotherapeutics, Inc. - USD -Infinity%
Xencor, Inc. 168.33 Million USD 99.475%
Orchestra BioMed Holdings, Inc. 2.76 Million USD 68.007%
Spruce Biosciences, Inc. 10.08 Million USD 91.248%
Coeptis Therapeutics Holdings, Inc. - USD -Infinity%
Vanda Pharmaceuticals Inc. 192.64 Million USD 99.542%
Lexaria Bioscience Corp. 226.2 Thousand USD -290.349%
Portage Biotech Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -5074.333%
Olema Pharmaceuticals, Inc. - USD -Infinity%
OncoCyte Corporation 1.5 Million USD 41.251%
Processa Pharmaceuticals, Inc. - USD -Infinity%
Purple Biotech Ltd. - USD -Infinity%
CollPlant Biotechnologies Ltd. 10.95 Million USD 91.943%
Onconetix, Inc. 58.46 Thousand USD -1410.305%
MacroGenics, Inc. 58.74 Million USD 98.497%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
Apogee Therapeutics, Inc. - USD -Infinity%
Neumora Therapeutics, Inc. Common Stock - USD -Infinity%
Ocuphire Pharma, Inc. 19.04 Million USD 95.365%
Prime Medicine, Inc. - USD -Infinity%
Aditxt, Inc. 645.17 Thousand USD -36.862%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Savara Inc. - USD -Infinity%
Curis, Inc. 10.02 Million USD 91.19%
Carmell Therapeutics Corporation - USD -Infinity%
Adagene Inc. 18.11 Million USD 95.125%
Achieve Life Sciences, Inc. - USD -Infinity%
BeiGene, Ltd. 2.45 Billion USD 99.964%
Inhibrx Biosciences, Inc. 1.8 Million USD 50.944%
GlycoMimetics, Inc. 10 Thousand USD -8730.0%
Maravai LifeSciences Holdings, Inc. 288.94 Million USD 99.694%
Protagenic Therapeutics, Inc. - USD -Infinity%
SciSparc Ltd. 2.87 Million USD 69.33%
Protagenic Therapeutics, Inc. - USD -Infinity%
Vincerx Pharma, Inc. - USD -Infinity%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. - USD -Infinity%
Fresh Tracks Therapeutics, Inc. 8 Million USD 88.971%
Arcutis Biotherapeutics, Inc. 59.6 Million USD 98.519%
Acrivon Therapeutics, Inc. Common Stock - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 99.952%
ADMA Biologics, Inc. 258.21 Million USD 99.658%
Rigel Pharmaceuticals, Inc. 116.88 Million USD 99.245%
Clene Inc. 654 Thousand USD -35.015%
Celldex Therapeutics, Inc. 6.88 Million USD 87.171%
Cogent Biosciences, Inc. - USD -Infinity%
Boundless Bio, Inc. Common Stock - USD -Infinity%
Recursion Pharmaceuticals, Inc. 44.57 Million USD 98.019%
Adicet Bio, Inc. - USD -Infinity%
Contineum Therapeutics, Inc. Class A Common Stock 50 Million USD 98.234%
Absci Corporation 5.71 Million USD 84.558%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 18.392%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Voyager Therapeutics, Inc. 250 Million USD 99.647%
Surrozen, Inc. - USD -Infinity%
Generation Bio Co. 5.9 Million USD 85.044%
Astria Therapeutics, Inc. - USD -Infinity%
Caribou Biosciences, Inc. 34.47 Million USD 97.439%
Black Diamond Therapeutics, Inc. - USD -Infinity%
Janux Therapeutics, Inc. 8.08 Million USD 89.076%
Invivyd, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Relay Therapeutics, Inc. 25.54 Million USD 96.543%
Quoin Pharmaceuticals, Ltd. - USD -Infinity%
Tenax Therapeutics, Inc. - USD -Infinity%
Spero Therapeutics, Inc. 96.73 Million USD 99.087%
Jaguar Health, Inc. 9.76 Million USD 90.954%
Artelo Biosciences, Inc. - USD -Infinity%
2seventy bio, Inc. 100.38 Million USD 99.12%
Clearside Biomedical, Inc. 8.22 Million USD 89.266%
Terns Pharmaceuticals, Inc. - USD -Infinity%
ACADIA Pharmaceuticals Inc. 726.43 Million USD 99.878%
Capricor Therapeutics, Inc. 25.17 Million USD 96.493%
Citius Pharmaceuticals, Inc. - USD -Infinity%
Relmada Therapeutics, Inc. - USD -Infinity%
Kronos Bio, Inc. 6.28 Million USD 85.957%
Innoviva, Inc. 310.46 Million USD 99.716%
Bolt Biotherapeutics, Inc. 7.87 Million USD 88.789%
Entrada Therapeutics, Inc. 129.01 Million USD 99.316%
ALX Oncology Holdings Inc. - USD -Infinity%
Vir Biotechnology, Inc. 86.18 Million USD 98.975%
Evaxion Biotech A/S 73.11 Thousand USD -1107.736%
Ocular Therapeutix, Inc. 58.44 Million USD 98.489%
Verve Therapeutics, Inc. 11.75 Million USD 92.49%
Tyra Biosciences, Inc. - USD -Infinity%
Galmed Pharmaceuticals Ltd. - USD -Infinity%
Unity Biotechnology, Inc. - USD -Infinity%
Connect Biopharma Holdings Limited - USD -Infinity%
Clearmind Medicine Inc. - USD -Infinity%
AlloVir, Inc. - USD -Infinity%
ORIC Pharmaceuticals, Inc. - USD -Infinity%
Catalyst Pharmaceuticals, Inc. 398.2 Million USD 99.778%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Viking Therapeutics, Inc. - USD -Infinity%
Keros Therapeutics, Inc. 151 Thousand USD -484.768%
SELLAS Life Sciences Group, Inc. - USD -Infinity%
Crinetics Pharmaceuticals, Inc. 4.01 Million USD 77.997%
ImmunityBio, Inc. 622 Thousand USD -41.961%
Korro Bio, Inc. - USD -Infinity%
C4 Therapeutics, Inc. 20.75 Million USD 95.746%
Kineta, Inc. 5.44 Million USD 83.774%
Lantern Pharma Inc. - USD -Infinity%
BioVie Inc. - USD -Infinity%
Codexis, Inc. 70.14 Million USD 98.741%
Celularity Inc. 22.77 Million USD 96.122%
Eledon Pharmaceuticals, Inc. - USD -Infinity%
Virax Biolabs Group Limited 156.41 Thousand USD -464.509%
Kodiak Sciences Inc. - USD -Infinity%
Cibus, Inc. 1.81 Million USD 51.403%
Annexon, Inc. - USD -Infinity%
Assembly Biosciences, Inc. 7.16 Million USD 87.673%
Moderna, Inc. 6.84 Billion USD 99.987%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 99.888%
Adverum Biotechnologies, Inc. 3.6 Million USD 75.472%
Avalo Therapeutics, Inc. 1.92 Million USD 54.106%
Immix Biopharma, Inc. - USD -Infinity%
Eyenovia, Inc. 3787.00 USD -23216.609%
Puma Biotechnology, Inc. 235.63 Million USD 99.625%
Monte Rosa Therapeutics, Inc. - USD -Infinity%
Wave Life Sciences Ltd. 113.3 Million USD 99.221%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Xilio Therapeutics, Inc. - USD -Infinity%
Alkermes plc 1.66 Billion USD 99.947%
Arcellx, Inc. 110.31 Million USD 99.2%
Moolec Science SA 905.04 Thousand USD 2.436%
Cardiff Oncology, Inc. 488 Thousand USD -80.943%
LAVA Therapeutics N.V. 6.76 Million USD 86.955%
Enanta Pharmaceuticals, Inc. 79.2 Million USD 98.885%
Regulus Therapeutics Inc. - USD -Infinity%
Atea Pharmaceuticals, Inc. - USD -Infinity%
Compass Therapeutics, Inc. - USD -Infinity%
Greenwich LifeSciences, Inc. - USD -Infinity%
Humacyte, Inc. - USD -Infinity%
Acumen Pharmaceuticals, Inc. - USD -Infinity%
Geron Corporation 237 Thousand USD -272.574%
Verrica Pharmaceuticals Inc. 5.12 Million USD 82.767%
Avenue Therapeutics, Inc. - USD -Infinity%
Royalty Pharma plc 2.35 Billion USD 99.962%
TFF Pharmaceuticals, Inc. 733.87 Thousand USD -20.321%
Notable Labs, Ltd. 310 Thousand USD -184.839%
Mersana Therapeutics, Inc. 36.85 Million USD 97.604%
Structure Therapeutics Inc. - USD -Infinity%
IN8bio, Inc. - USD -Infinity%
89bio, Inc. - USD -Infinity%
DiaMedica Therapeutics Inc. - USD -Infinity%
Vera Therapeutics, Inc. 1.86 Million USD 52.578%
Acasti Pharma Inc. - USD -Infinity%
Genelux Corporation 170 Thousand USD -419.412%
Trevi Therapeutics, Inc. - USD -Infinity%
Liquidia Corporation 17.48 Million USD 94.951%
Mustang Bio, Inc. - USD -Infinity%
Immunovant, Inc. - USD -Infinity%
Vericel Corporation 197.51 Million USD 99.553%
Quantum-Si incorporated 1.08 Million USD 18.392%
Arbutus Biopharma Corporation 18.14 Million USD 95.133%
XOMA Corporation 4.75 Million USD 81.442%
ARS Pharmaceuticals, Inc. 30 Thousand USD -2843.333%
MiNK Therapeutics, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
Vaxcyte, Inc. - USD -Infinity%
Xenon Pharmaceuticals Inc. - USD -Infinity%
Estrella Immunopharma, Inc. - USD -Infinity%
NeuroBo Pharmaceuticals, Inc. - USD -Infinity%
Tempest Therapeutics, Inc. - USD -Infinity%
Sol-Gel Technologies Ltd. 1.55 Million USD 43.179%
Rhythm Pharmaceuticals, Inc. 77.42 Million USD 98.86%
Soleno Therapeutics, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. - USD -Infinity%
PepGen Inc. - USD -Infinity%
Moleculin Biotech, Inc. - USD -Infinity%
United Therapeutics Corporation 2.32 Billion USD 99.962%
Solid Biosciences Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Immuneering Corporation - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. 72.1 Thousand USD -1124.654%
Telomir Pharmaceuticals, Inc. Common Stock - USD -Infinity%
Belite Bio, Inc - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.64%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Bionomics Limited - USD -Infinity%
Pyxis Oncology, Inc. - USD -Infinity%
uniQure N.V. 15.84 Million USD 94.427%
Windtree Therapeutics, Inc. - USD -Infinity%
GeoVax Labs, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 64.7 Million USD 98.635%
Altimmune, Inc. 426 Thousand USD -107.277%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD -140.026%
SeaStar Medical Holding Corporation - USD -Infinity%
FibroBiologics, Inc. Common Stock - USD -Infinity%
Benitec Biopharma Inc. 216 Thousand USD -308.796%
Zura Bio Limited - USD -Infinity%
Amicus Therapeutics, Inc. 399.35 Million USD 99.779%
Salarius Pharmaceuticals, Inc. - USD -Infinity%
Compugen Ltd. 33.45 Million USD 97.361%
Elevai Labs, Inc. Common Stock 1.71 Million USD 48.441%
argenx SE 1.22 Billion USD 99.928%
Zevra Therapeutics, Inc. 27.46 Million USD 96.785%
Nuvectis Pharma, Inc. - USD -Infinity%
Spyre Therapeutics, Inc. 886 Thousand USD 0.339%
NKGen Biotech, Inc. Common Stock - USD -Infinity%
Madrigal Pharmaceuticals, Inc. - USD -Infinity%
PolyPid Ltd. - USD -Infinity%
Aileron Therapeutics, Inc. - USD -Infinity%
Plus Therapeutics, Inc. 4.91 Million USD 82.027%
Forte Biosciences, Inc. - USD -Infinity%
Dianthus Therapeutics, Inc. 2.82 Million USD 68.754%
Instil Bio, Inc. - USD -Infinity%
Elevation Oncology, Inc. - USD -Infinity%
Immunome, Inc. 14.01 Million USD 93.701%
Verona Pharma plc - USD -Infinity%
Enveric Biosciences, Inc. - USD -Infinity%
enGene Holdings Inc. Warrants - USD -Infinity%
Shattuck Labs, Inc. 1.65 Million USD 46.711%
LENZ Therapeutics, Inc. - USD -Infinity%
Design Therapeutics, Inc. - USD -Infinity%
Leap Therapeutics, Inc. - USD -Infinity%
Seelos Therapeutics, Inc. 2.2 Million USD 59.918%
Achilles Therapeutics plc - USD -Infinity%
Fractyl Health, Inc. Common Stock 120 Thousand USD -635.833%
Rani Therapeutics Holdings, Inc. - USD -Infinity%
MoonLake Immunotherapeutics - USD -Infinity%
Beam Therapeutics Inc. 377.7 Million USD 99.766%
Moolec Science SA 905.04 Thousand USD 2.436%
Longboard Pharmaceuticals, Inc. - USD -Infinity%
AEON Biopharma, Inc. - USD -Infinity%
Aadi Bioscience, Inc. 24.35 Million USD 96.374%
Enliven Therapeutics, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 1.18 Million USD 25.736%
Taysha Gene Therapies, Inc. 15.45 Million USD 94.285%
Inovio Pharmaceuticals, Inc. 832.01 Thousand USD -6.129%
Athira Pharma, Inc. - USD -Infinity%
HCW Biologics Inc. 2.84 Million USD 68.928%
XOMA Corporation 4.75 Million USD 81.442%
NeurAxis, Inc. 2.46 Million USD 64.106%
Lumos Pharma, Inc. 2.05 Million USD 56.948%
enGene Holdings Inc. Common Stock - USD -Infinity%
180 Life Sciences Corp. - USD -Infinity%
Nektar Therapeutics 90.12 Million USD 99.02%
NKGen Biotech, Inc. Warrants - USD -Infinity%
Opiant Pharmaceuticals, Inc. 40.72 Million USD 97.832%
Arvinas, Inc. 78.5 Million USD 98.875%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Palisade Bio, Inc. 250 Thousand USD -253.2%
Nutriband Inc. 2.08 Million USD 57.656%
Tevogen Bio Holdings Inc. - USD -Infinity%
CG Oncology, Inc. Common stock 204 Thousand USD -332.843%
Tourmaline Bio, Inc. - USD -Infinity%
Merus N.V. 43.94 Million USD 97.991%
Omega Therapeutics, Inc. 3.09 Million USD 71.461%
Neurogene Inc. - USD -Infinity%
Mirum Pharmaceuticals, Inc. 186.37 Million USD 99.526%
Kintara Therapeutics, Inc. - USD -Infinity%
CervoMed Inc. 7.14 Million USD 87.641%
CARGO Therapeutics, Inc. Common Stock - USD -Infinity%
Sesen Bio, Inc. 40 Million USD 97.793%
Quince Therapeutics, Inc. - USD -Infinity%
Rezolute, Inc. - USD -Infinity%
Clene Inc. 654 Thousand USD -35.015%
Indaptus Therapeutics, Inc. - USD -Infinity%
BeyondSpring Inc. 1.75 Million USD 49.572%
Synlogic, Inc. 3.37 Million USD 73.806%
Allarity Therapeutics, Inc. - USD -Infinity%
Phio Pharmaceuticals Corp. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD -140.026%
Werewolf Therapeutics, Inc. 19.94 Million USD 95.572%
Krystal Biotech, Inc. 50.69 Million USD 98.258%
Karyopharm Therapeutics Inc. 146.03 Million USD 99.395%
SpringWorks Therapeutics, Inc. 5.44 Million USD 83.789%
Lipella Pharmaceuticals Inc. 449.61 Thousand USD -96.389%
MannKind Corporation 198.96 Million USD 99.556%
Ikena Oncology, Inc. 9.16 Million USD 90.36%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 113.45 Million USD 99.222%
Gossamer Bio, Inc. - USD -Infinity%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Legend Biotech Corporation 285.14 Million USD 99.69%
Mural Oncology plc - USD -Infinity%
Disc Medicine, Inc. - USD -Infinity%
Champions Oncology, Inc. 50.15 Million USD 98.239%
REGENXBIO Inc. 90.24 Million USD 99.022%
Ensysce Biosciences, Inc. 2.23 Million USD 60.413%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. - USD -Infinity%
Edgewise Therapeutics, Inc. - USD -Infinity%
Vaxart, Inc. 7.37 Million USD 88.034%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. - USD -Infinity%
Cellectis S.A. 755 Thousand USD -16.954%
Longeveron Inc. 709 Thousand USD -24.542%
Repare Therapeutics Inc. 51.13 Million USD 98.273%
Sarepta Therapeutics, Inc. 1.24 Billion USD 99.929%
Inozyme Pharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. 11.58 Million USD 92.375%
Nymox Pharmaceutical Corporation - USD -Infinity%
Third Harmonic Bio, Inc. - USD -Infinity%
ArriVent BioPharma, Inc. Common Stock - USD -Infinity%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 210 Thousand USD -320.476%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 99.991%
Denali Therapeutics Inc. 330.53 Million USD 99.733%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 16.29 Million USD 94.582%
Corvus Pharmaceuticals, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Passage Bio, Inc. - USD -Infinity%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. - USD -Infinity%
Day One Biopharmaceuticals, Inc. - USD -Infinity%
Oramed Pharmaceuticals Inc. 2.7 Million USD 67.333%
Scinai Immunotherapeutics Ltd. - USD -Infinity%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 152.43 Thousand USD -479.282%
Carisma Therapeutics, Inc. 14.91 Million USD 94.081%
Unicycive Therapeutics, Inc. 675 Thousand USD -30.815%
OmniAb, Inc. 34.16 Million USD 97.415%
Anew Medical, Inc. - USD -Infinity%
Fennec Pharmaceuticals Inc. 21.25 Million USD 95.845%
Lipocine Inc. -2.85 Million USD 130.974%
Lexeo Therapeutics, Inc. Common Stock - USD -Infinity%
Nautilus Biotechnology, Inc. - USD -Infinity%
SAB Biotherapeutics, Inc. 2.23 Million USD 60.563%
G1 Therapeutics, Inc. 82.51 Million USD 98.93%
Bellerophon Therapeutics, Inc. - USD -Infinity%
Sage Therapeutics, Inc. 86.45 Million USD 98.979%
Ocugen, Inc. 6.03 Million USD 85.371%
Mind Medicine (MindMed) Inc. - USD -Infinity%
Q32 Bio Inc. 1.15 Million USD 23.616%
Brainstorm Cell Therapeutics Inc. - USD -Infinity%
Alumis Inc. Common Stock - USD -Infinity%
Equillium, Inc. 36.08 Million USD 97.553%
Kyverna Therapeutics, Inc. - USD -Infinity%
Coya Therapeutics, Inc. 6 Million USD 85.289%
CNS Pharmaceuticals, Inc. - USD -Infinity%
Dominari Holdings Inc. 2.03 Million USD 56.694%
Edesa Biotech, Inc. - USD -Infinity%
vTv Therapeutics Inc. - USD -Infinity%
Bio-Techne Corporation 1.15 Billion USD 99.924%
Agios Pharmaceuticals, Inc. 26.82 Million USD 96.708%
Harmony Biosciences Holdings, Inc. 582.02 Million USD 99.848%
Prelude Therapeutics Incorporated - USD -Infinity%
Candel Therapeutics, Inc. - USD -Infinity%
iTeos Therapeutics, Inc. 12.59 Million USD 92.989%
Nkarta, Inc. - USD -Infinity%
BioCardia, Inc. 477 Thousand USD -85.115%
Iterum Therapeutics plc - USD -Infinity%